Predicting Bacterial Versus Viral Infection, or None of the Above
Tóm tắt
Từ khóa
Tài liệu tham khảo
Heron, 2018, Deaths: leading causes for 2016, Natl Vital Stat Rep, 67, 1
Vincent, 2014, Assessment of the worldwide burden of critical illness: the Intensive Care over Nations (ICON) audit, Lancet Respir Med, 2, 380, 10.1016/S2213-2600(14)70061-X
Singer, 2016, The third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA, 315, 801, 10.1001/jama.2016.0287
Rudd, 2018, The global burden of sepsis: barriers and potential solutions, Crit Care, 22, 232, 10.1186/s13054-018-2157-z
Reinhart, 2017, Recognizing sepsis as a global health priority – A WHO Resolution, N Engl J Med, 377, 414, 10.1056/NEJMp1707170
Kapasi, 2016, Host biomarkers distinguishing bacterial from non-bacterial causes of acute febrile illness: a comprehensive review, PLoS One, 11, e0160278, 10.1371/journal.pone.0160278
Saeed, 2019, The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multicentre derivation and validation study, Crit Care, 23, 40, 10.1186/s13054-019-2329-5
Kumar, 2011, Pathogen recognition by the innate immune system, Int Rev Immunol, 30, 16, 10.3109/08830185.2010.529976
Dolasia, 2018, TLRs/NLRs: shaping the landscape of host immunity, Int Rev Immunol, 37, 3, 10.1080/08830185.2017.1397656
Bone, 1992, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Crit Care Med, 20, 864, 10.1097/00003246-199206000-00025
Dellinger, 2008, Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, Crit Care Med, 36, 296, 10.1097/01.CCM.0000298158.12101.41
Wunderink, 2018, Guidelines to manage community-acquired pneumonia, Clin Chest Med, 39, 723, 10.1016/j.ccm.2018.07.006
Sungurlu, 2018, The role of biomarkers in the diagnosis and management of pneumonia, Clin Chest Med, 39, 691, 10.1016/j.ccm.2018.07.004
Ahnert, 2019, Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community-acquired pneumonia – results from the prospective observational PROGRESS study, Crit Care, 23, 110, 10.1186/s13054-019-2316-x
Fernandez, 2012, Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers, Expert Rev Clin Pharmacol, 5, 445, 10.1586/ecp.12.28
Zhydkov, 2015, Utility of procalcitonin, C-reactive protein, and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia, Clin Chem Lab Med, 53, 559, 10.1515/cclm-2014-0456
Seymour, 2016, Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA, 315, 762, 10.1001/jama.2016.0288
Magadia, 2001, Laboratory diagnosis of bacteremia and fungemia, Infect Dis Clin North Am, 15, 1009, 10.1016/S0891-5520(05)70184-7
Riedel, 2010, Blood cultures: key elements for best practices and future directions, J Infect Chemother, 16, 301, 10.1007/s10156-010-0069-1
Martin, 2003, The epidemiology of sepsis in the United States from 1979 through 2000, N Engl J Med, 348, 1546, 10.1056/NEJMoa022139
Bochud, 2004, Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence based review, Crit Care Med, 32, S495, 10.1097/01.CCM.0000143118.41100.14
Phua, 2013, Characteristics and outcomes of culture-negative versus culture-positive severe sepsis, Crit Care, 17, R202, 10.1186/cc12896
Bethesda, 2001, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin Pharmacol Ther, 69, 89, 10.1067/mcp.2001.113989
Gluck, 2018, Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: a retrospective, observational study, PLoS One, 13, e0205924, 10.1371/journal.pone.0205924
Gabay, 1999, Acute-phase proteins and other systemic responses to inflammation, N Engl J Med, 340, 448, 10.1056/NEJM199902113400607
Lelubre, 2013, Interpretation of C-reactive protein concentrations in critically ill patients, Biomed Res Int, 2013, 124021, 10.1155/2013/124021
Vincent, 2011, Biomarkers in the critically ill patient: C-reactive protein, Crit Care Clin, 27, 241, 10.1016/j.ccc.2010.12.010
Eschborn, 2019, Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis, J Perinatol, 10.1038/s41372-019-0363-4
Riedel, 2013, Laboratory detection of sepsis: biomarkers and molecular approaches, Clin Lab Med, 33, 413, 10.1016/j.cll.2013.03.006
Nora, 2017, Biomarker-guided antibiotic therapy – strengths and limitations, Ann Transl Med, 5, 208, 10.21037/atm.2017.04.04
Mantovani, 2008, Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3, J Clin Immunol, 28, 1, 10.1007/s10875-007-9126-7
Albert Vega, 2019, Source of circulating pentraxin 3 in septic shock patients, Front Immunol, 9, 3048, 10.3389/fimmu.2018.03048
Inforzato, 2012, Pentraxins in humoral immunity, Adv Exp Med Biol, 946, 1, 10.1007/978-1-4614-0106-3_1
Mauri, 2010, Persisting high levels of pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality, Intensive Care Med, 36, 621, 10.1007/s00134-010-1752-5
Hamed, 2017, Diagnostic value of pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions, BMC Infect Dis, 17, 554, 10.1186/s12879-017-2606-3
deKruif, 2010, PTX3 predicts severe disease in febrile patients in the emergency department, J Infect, 60, 122
Uusitalo-Seppälä, 2013, Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study, PLoS One, 8, e53661, 10.1371/journal.pone.0053661
Riedel, 2012, Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis, Diagn Microbiol Infect Dis, 73, 221, 10.1016/j.diagmicrobio.2012.05.002
Assicot, 1993, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet, 341, 515, 10.1016/0140-6736(93)90277-N
Meisner, 2002, Pathobiochemistry and clinical use of procalcitonin, Clin Chim Acta, 323, 17, 10.1016/S0009-8981(02)00101-8
Mueller, 2001, Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis, J Clin Endocrinol Metab, 86, 396
Brunkhorst, 1998, Kinetics of procalcitonin in iatrogenic sepsis, Intensive Care Med, 24, 888, 10.1007/s001340050683
Becker, 2004, Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors, J Clin Endocrinol Metab, 89, 1512, 10.1210/jc.2002-021444
Mueller, 2002, High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of decoy receptor levels with glucocorticoid administration, J Leukoc Biol, 72, 643, 10.1189/jlb.72.4.643
Mueller, 2010, Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective clinical trial, Chest, 138, 121, 10.1378/chest.09-2920
DeKruif, 2010, Additional value of procalcitonin for diagnosis of infection in patients with fever in the emergency department, Crit Care Med, 38, 457, 10.1097/CCM.0b013e3181b9ec33
Riedel, 2011, Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department, Am J Clin Pathol, 135, 182, 10.1309/AJCP1MFYINQLECV2
Jeong, 2012, Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture, Clin Chim Acta, 413, 1731, 10.1016/j.cca.2012.06.030
Liu, 2017, Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria, Ir J Med Sci, 186, 207, 10.1007/s11845-016-1457-z
Thomas-Rüddel, 2018, Influence of pathogen and focus of infection on procalcitonin levels in sepsis patients with bacteremia or candidemia, Crit Care, 22, 128, 10.1186/s13054-018-2050-9
Schuetz, 2007, Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci, Infection, 35, 352, 10.1007/s15010-007-7065-0
Lai, 2010, Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department, J Am Geriatr Soc, 58, 518, 10.1111/j.1532-5415.2010.02730.x
Fioretto, 2010, Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis and septic shock, Inflamm Res, 59, 581, 10.1007/s00011-010-0161-0
Jones, 2007, Procalcitonin test in the diagnosis of bacteremia: a meta-analysis, Ann Emerg Med, 50, 34, 10.1016/j.annemergmed.2006.10.020
Simon, 2004, Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis, Clin Infect Dis, 39, 206, 10.1086/421997
Uzzan, 2006, Procalcitonin as a diagnostic test for sepsis in critically ill adults after surgery or trauma: a systematic review and meta-analysis, Crit Care Med, 34, 1996, 10.1097/01.CCM.0000226413.54364.36
Vouloumanou, 2011, Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis, Intensive Care Med, 37, 747, 10.1007/s00134-011-2174-8
Wacker, 2013, Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis, Lancet Infect Dis, 14, 426, 10.1016/S1473-3099(12)70323-7
Pontrelli, 2017, Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis, BMC Infect Dis, 17, 302, 10.1186/s12879-017-2396-7
Kibe, 2011, Diagnostic and prognostic biomarkers of sepsis in critical care, J Antimicrob Chemother, 66, 33
Ruiz-Alvarez, 2009, Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis, J Intensive Care Med, 24, 63, 10.1177/0885066608327095
Nobre, 2008, Use of procalcitonin to shorten antibiotic treatment duration in septic patients, Am J Respir Crit Care Med, 177, 498, 10.1164/rccm.200708-1238OC
Bouadma, 2010, Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial, Lancet, 375, 463, 10.1016/S0140-6736(09)61879-1
Agrawal, 2011, Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review, Clin Infect Dis, 53, 379, 10.1093/cid/cir408
Schuetz, 2011, Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendation for clinical algorithms, Arch Intern Med, 171, 1322, 10.1001/archinternmed.2011.318
Schuetz, 2017, Serial procalcitonin predicts mortality in severe sepsis patients: results from the Multicenter Procalcitonin Monitoring Sepsis (MOSES) study, Crit Care Med, 45, 781, 10.1097/CCM.0000000000002321
Wirz, 2018, Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials, Crit Care, 22, 191, 10.1186/s13054-018-2125-7
Chu, 2017, Practice patterns and outcomes associated with procalcitonin use in critically ill patients with sepsis, Clin Infect Dis, 64, 1509, 10.1093/cid/cix179
Hinson, 2000, Adrenomedullin, a multifunctional regulatory peptide, Endocr Rev, 21, 138
Hirata, 1996, Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis, J Clin Endocrinol Metab, 81, 1449
Christ-Crain, 2005, Mid-regional proadrenomedullin as a prognostic marker in sepsis: an observational study, Crit Care, 9, R816, 10.1186/cc3885
Guignant, 2009, Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients, Intensive Care Med, 35, 1859, 10.1007/s00134-009-1610-5
Debiane, 2014, The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infection in critically ill patients with cancer, Crit Care Med, 42, 2500, 10.1097/CCM.0000000000000526
Gunnar, 2018, The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis – a secondary analysis of a larger randomised controlled trial, Crit Care, 22, 79, 10.1186/s13054-018-2001-5
Viaggi, 2018, Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study, PLoS One, 13, e0201491, 10.1371/journal.pone.0201491
Analuz-Ojeda, 2017, Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity, Ann Intensive Care, 7, 15, 10.1186/s13613-017-0238-9
Li, 2018, Assessment of adrenomedullin and proadrenomedullin as predictors of mortality in septic patients: a systematic review and meta-analysis, Med Intensiva, 42, 416, 10.1016/j.medin.2017.10.013
Trzeciak, 2007, Serum lactate as a predictor of mortality in patients with infection, Intensive Care Med, 33, 970, 10.1007/s00134-007-0563-9
Puskarich, 2013, Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock, Chest, 143, 1548, 10.1378/chest.12-0878
Singer, 2014, Diagnostic characteristics of a clinical screening tool in combination with measuring bedside lactate level in emergency department patients with suspected sepsis, Acad Emerg Med, 21, 853, 10.1111/acem.12444
Anderson, 2013, Etiology and therapeutic approach to elevated lactate, Mayo Clin Proc, 88, 1127, 10.1016/j.mayocp.2013.06.012
Dugas, 2012, Prevalence and characteristics of nonlactate and lactate expressors in septic shock, J Crit Care, 27, 344, 10.1016/j.jcrc.2012.01.005
Kuster, 1998, Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestations, Lancet, 352, 1271, 10.1016/S0140-6736(98)08148-3
Uusitalo-Seppälä, 2011, Early detection of severe sepsis in the emergency room: diagnostic value of C-reactive protein, procalcitonin, and interleukin-6, Scand J Infect Dis, 43, 883, 10.3109/00365548.2011.600325
Andaluz-Ojeda, 2012, A combined score of pro- and antiinflammatory interleukins improves mortality prediction in severe sepsis, Cytokine, 57, 332, 10.1016/j.cyto.2011.12.002
Meem, 2011, Biomarkers for diagnosis of neonatal infections: a systematic analysis of their potential as a point-of-care diagnostics, J Glob Health, 1, 201
Bouchon, 2001, TREM-1 amplifies inflammation and is a crucial mediator of sepsis, Nature, 410, 1103, 10.1038/35074114
Wu, 2012, Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis, Crit Care, 16, R229, 10.1186/cc11884
Cao, 2017, Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases, Front Med, 11, 169, 10.1007/s11684-017-0505-z
Shozushima, 2011, Usefulness of presepsin sCD14-ST measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria for systemic inflammatory response syndrome, J Infect Chemother, 17, 764, 10.1007/s10156-011-0254-x
Endo, 2012, Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study, J Infect Chemother, 18, 891, 10.1007/s10156-012-0435-2
Christ-Crain, 2008, Biomarkers in the management of pneumonia, Expert Rev Respir Med, 2, 565, 10.1586/17476348.2.5.565
Mueller, 2007, Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia, BMC Infect Dis, 7, 10, 10.1186/1471-2334-7-10
Moulin, 2001, Procalcitonin in children admitted to hospital with community acquired pneumonia, Arch Dis Child, 84, 332, 10.1136/adc.84.4.332
Johansson, 2014, Procalcitonin levels in community-acquired pneumonia – correlation with aetiology and severity, Scand J Infect Dis, 46, 787, 10.3109/00365548.2014.945955
Suberviola, 2012, Prognostic value of proadrenomedullin in severe sepsis and septic shock with community-acquired pneumonia, Swiss Med Wkly, 142, w13542
Cavallazzi, 2014, Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review, Respir Med, 108, 1569, 10.1016/j.rmed.2014.09.018
Schuetz, 2009, Effect of procalcitonin-based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial, JAMA, 302, 1059, 10.1001/jama.2009.1297
Branche, 2019, Procalcitonin to guide antibiotic decision making, Curr Opin Infect Dis, 32, 130, 10.1097/QCO.0000000000000522
Schuetz, 2018, Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient-level meta-analysis, Lancet Infect Dis, 19, 95, 10.1016/S1473-3099(17)30592-3
Huang, 2018, Procalcitonin-guided use of antibiotics for lower respiratory tract infection, N Engl J Med, 379, 236, 10.1056/NEJMoa1802670
Lam, 2018, Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies, Crit Care Med, 46, 684, 10.1097/CCM.0000000000002953
Velissaris, 2018, The role of procalcitonin in the diagnosis of meningitis: a literature review, J Clin Med, 7, 148
Li, 2017, Diagnostic accuracy of cerebrospinal fluid procalcitonin in bacterial meningitis patients with empiric antibiotic pretreatment, J Clin Microbiol, 55, 1193, 10.1128/JCM.02018-16
Drozdov, 2015, Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial, BMC Med, 13, 104, 10.1186/s12916-015-0347-y
Serkova, 2011, The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses, Am J Respir Crit Care, 184, 647, 10.1164/rccm.201103-0474CI
Goh, 2017, Enhanced understanding of the host-pathogen interaction in sepsis: new opportunities for omic approaches, Lancet Respir Med, 5, 212, 10.1016/S2213-2600(17)30045-0
Sweeney, 2016, Robust classification of bacterial and viral infections via integrated host gene expression diagnostics, Sci Transl Med, 8, 346ra91